POINT Biopharma Corp. Employment AgreementEmployment Agreement • March 23rd, 2021 • Therapeutics Acquisition Corp. • Blank checks • Ontario
This Agreement (as defined below) sets out the terms and conditions of your employment by the Company and will constitute your employment agreement.
POINT Biopharma Corp. Employment AgreementTherapeutics Acquisition Corp. • March 23rd, 2021 • Blank checks • Ontario
This Agreement (as defined below) sets out the terms and conditions of your employment by the Company and will constitute your employment agreement.
EXCLUSIVE LICENSE AND COMMERCIALIZATION AGREEMENTExclusive License and Commercialization Agreement • March 23rd, 2021 • Therapeutics Acquisition Corp. • Blank checks • Ontario
This Exclusive License and Commercialization Agreement (this “Agreement”), dated as of 16 December 2020 (“Effective Date”), is made by and between POINT Biopharma Inc., having an address 4850 West 78th Street, Indianapolis, Indiana 46268, United States (“POINT”); Canadian Molecular Probe Consortium having a business office at C/O CPDC, Nuclear Research Building - A316, 1280 Main Street West, Hamilton, Ontario, Canada, L8S 4K1 (“CanProbe”); the Centre for Probe Development and Commercialization having a business office at Nuclear Research Building - A316, 1280 Main Street West, Hamilton, Ontario, Canada, L8S 4K1 (“CPDC”); and the University Health Network having a business office at 101 College Street, Suite 150, Heritage Building, MaRS Centre, Toronto, Ontario M5G 1L7 Canada (“UHN”). CanProbe, CPDC and UHN are collectively referred to herein as “Licensor”. Each of POINT, CanProbe, CPDC and UHN may be referred to herein as a “Party” or together as “Parties”.
POINT Biopharma USA Inc. Employment AgreementTherapeutics Acquisition Corp. • March 23rd, 2021 • Blank checks • New York
This Agreement (as defined below) sets out the terms and conditions of your employment by the Company and will constitute your employment agreement.
LOAN AND SECURITY AGREEMENT dated as of July 10, 2020 between WEST 78th STREET, LLC as Borrower, and CIBC BANK USA, as LenderLoan and Security Agreement • March 23rd, 2021 • Therapeutics Acquisition Corp. • Blank checks
THIS LOAN AND SECURITY AGREEMENT dated as of July 10, 2020 (this “Agreement”) is entered into among WEST 78th STREET, LLC, an Indiana limited liability company (“Borrower”), and CIBC BANK USA (“CIBC US”), as Lender.
CONSULTING AGREEMENTConsulting Agreement • March 23rd, 2021 • Therapeutics Acquisition Corp. • Blank checks • Ontario
This Consulting Agreement (this “Agreement”) is entered into as of the February 22, 2021 (“Effective Date”) and ending December 31, 2021 (“End Date”) by and between POINT Biopharma Inc., a corporation duly incorporated under the laws of Delaware (“POINT” or the “Company”), and between Dr Neil Fleshner, 1510789 Ontario Inc. with a registered office at 610 University Ave. Suite 3-130 Toronto, Ontario (“Consultant”). POINT and Consultant are hereinafter collectively referred to as the “Parties” or singularly as the “Party.” In consideration of the mutual covenants contained herein, the Parties agree to the following terms and conditions:
